Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A malaria vaccine has shown promising results in early stage clinical trials, a study suggests.
Researchers found the vaccine, which is being developed in the US, protected 12 out of 15 patients from the disease, when given in high doses.
The method is unusual because it involves injecting live but weakened malaria-causing parasites directly into patients to trigger immunity.
The research is published in the journal Science.
http://www.bbc.co.uk/news/health-23607612
Researchers found the vaccine, which is being developed in the US, protected 12 out of 15 patients from the disease, when given in high doses.
The method is unusual because it involves injecting live but weakened malaria-causing parasites directly into patients to trigger immunity.
The research is published in the journal Science.
http://www.bbc.co.uk/news/health-23607612